| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |